Anwar Galvanizing Limited (DSE:ANWARGALV)

Verve Therapeutics Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	2,095	4,033	6,439	7,109	3,174	980
Market Cap Growth	-55.71%	-37.36%	-9.43%	123.96%	223.87%	-12.79%
Enterprise Value	2,698	4,015	6,398	7,120	3,195	943
Last Close Price	69.40	131.70	209.29	229.87	102.09	31.29
PE Ratio	-	49.11	108.18	36.74	53.15	33.23
PS Ratio	3.69	6.28	8.73	9.81	5.20	1.84
PB Ratio	34.66	9.09	16.44	19.43	15.65	6.22
P/TBV Ratio	34.66	9.09	16.44	19.43	15.65	6.22
P/FCF Ratio	-	442.89	-	-	-	26.87
P/OCF Ratio	-	69.00	99.48	544.38	-	19.09
EV/Sales Ratio	4.75	6.25	8.67	9.83	5.24	1.77
EV/EBITDA Ratio	-	89.35	125.09	81.57	42.66	19.17
EV/EBIT Ratio	-	142.92	157.31	92.71	49.35	23.67
EV/FCF Ratio	-24.77	440.89	-	-	-	25.86
Debt / Equity Ratio	10.11	1.03	0.74	0.61	0.49	0.12
Debt / EBITDA Ratio	-	9.81	5.66	2.55	1.33	0.38
Debt / FCF Ratio	-	50.26	-	-	-	0.51
Asset Turnover	0.65	0.69	0.97	1.24	1.70	1.94
Inventory Turnover	2.52	2.73	2.92	2.66	3.20	3.84
Quick Ratio	0.04	0.88	0.82	0.82	0.14	0.29
Current Ratio	0.47	1.37	1.43	1.65	1.34	1.65
Return on Equity (ROE)	-41.97%	19.66%	15.71%	68.05%	33.14%	19.63%
Return on Assets (ROA)	-5.95%	1.89%	3.33%	8.24%	11.25%	9.03%
Return on Capital (ROIC)	-7.37%	2.22%	4.01%	10.78%	16.90%	15.60%
Return on Capital Employed (ROCE)	-	5.20%	9.60%	19.70%	30.60%	23.90%
Earnings Yield	-5.65%	2.04%	0.92%	2.72%	1.88%	3.01%
FCF Yield	-5.20%	0.23%	-0.63%	-0.40%	-1.95%	3.72%
Dividend Yield	1.44%	0.76%	0.48%	0.48%	0.99%	1.54%
Payout Ratio	-	37.11%	64.53%	18.86%	29.02%	36.22%
Total Shareholder Return	1.44%	0.76%	0.48%	0.48%	0.99%	1.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.